Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate

Dev Med Child Neurol. 1991 Jun;33(6):524-34. doi: 10.1111/j.1469-8749.1991.tb14917.x.

Abstract

Sixty-four new cases of childhood epilepsy were randomly assigned to either carbamazepine, phenytoin or sodium valproate, and were assessed with cognitive tests before medication and three subsequent times over a year. Carbamazepine in moderate dosage adversely affected memory, but sodium valproate and phenytoin did not.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anticonvulsants / adverse effects
  • Anticonvulsants / blood
  • Anticonvulsants / therapeutic use*
  • Carbamazepine / therapeutic use
  • Child
  • Child, Preschool
  • Cognition / drug effects*
  • Epilepsy / drug therapy*
  • Epilepsy / psychology
  • Humans
  • Intelligence Tests
  • Phenytoin / therapeutic use
  • Random Allocation
  • Valproic Acid / therapeutic use

Substances

  • Anticonvulsants
  • Carbamazepine
  • Valproic Acid
  • Phenytoin